Advertisement
News
Subscribe to MDT Magazine News

Roche's Genentech says Lucentis met goal in study

February 11, 2011 9:45 am | by The Associated Press | Comments

Swiss drugmaker Roche said Friday a clinical trial showed its eye drug Lucentis is effective as a treatment for macular edema bought on by diabetes.Roche's Genentech unit said Lucentis was more effective than a placebo injection in the late-stage clinical study. A total of 377 patients were...

Vitalitec buys surgical device from Novare

February 11, 2011 9:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Vitalitec International Inc. announced it has acquired the technology and rights to a medical device that assists during coronary bypass surgery from California company Novare Surgical Systems Inc.

TOPICS:

Acute anemia linked to silent strokes in children

February 11, 2011 9:34 am | by EurekAlert | Comments

(American Heart Association) Symptomless strokes occur in about 20 percent of children with sickle cell disease when their red blood cell levels severely drop. These silent strokes also occur in about 7 percent of hospitalized children without sickle cell who have severe drops in...

TOPICS:
Advertisement

Dana-Farber researchers find cause of declining health in elderly

February 11, 2011 9:33 am | by Mass High Tech: The Journal of New England Technology | Comments

A team of scientists at Dana-Farber Cancer Institute led by Dr. Ronald A DePinho reports that they have identified the root cause of a variety of age-related ailments such as waning energy, heart failure, failure of other organs and metabolic disorders including diabetes.

Report: Medicare drug program vulnerable to fraud

February 11, 2011 8:45 am | by KELLI KENNEDY - Associated Press - Associated Press | Comments

Crooks are taking advantage of lax oversight in Medicare's Part D prescription drug program to obtain highly addictive drugs including oxycodone, Ritalin, and methadone, according to results of a federal probe.The report by an independent inspector says Medicare can't verify all the...

Tufts launches Institute for Biopharmaceutical Partnerships

February 11, 2011 8:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Tufts University has launched the Tufts Institute for Biomedical Partnerships, designed to help move the portfolio of research into commercial drug discovery and development partnerships.

Orthovita: FDA clears new version of Vitoss graft

February 11, 2011 6:45 am | by MARLEY SEAMAN - AP Health Writer - Associated Press | Comments

Shares of Orthovita Inc. advanced Friday after the company said it received marketing clearance for a new version of its Vitoss bone graft product.Orthovita said it plans to start selling the product in late 2011 or early 2012.Late Thursday, the Malvern, Pa., company said the Food and Drug...

Instead of Preventing Infections, Silver Coated Needleless IV Connectors May Actually Cause Them, a Nationally-Recognized Expert Tells National Conference on Cancer Nursing Re...

February 11, 2011 6:34 am | by Bio-Medicine.Org | Comments

LOS ANGELES, Feb. 11, 2011 /- Nationally-acclaimed researcher and award-winning author Dr. Cynthia C. Chernecky warned in a speech at the 11th National Conference on Cancer Nursing Research that silver treated IV connectors could actually cause potentially deadly infections they were...

TOPICS:
Advertisement

Limitless Possibilities at RAPID 2011 — See and Hear How Technology is Revolutionizing Product Creation

February 11, 2011 5:35 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich. Feb 10, 2011 — RAPID 2011, a conference and exposition showcasing how additive manufacturing is used to create almost any solid product while reducing production costs, will be held in Minneapolis, May 24–26, 2011. More

Sports Icon Billie Jean King Gets Back in the Game with Help from New Knees

February 11, 2011 4:37 am | by Bio-Medicine.Org | Comments

MEMPHIS, Tenn., Feb. 11, 2011 /- Today, Smith & Nephew, Inc. (LSE: SN; NYSE: SNN ) announced it is partnering with famed sports icon and humanitarian Billie Jean King to highlight her success following her double knee replacement with a Smith & Nephew product. One year ago, King...

TOPICS:

Mindray to Report Fourth Quarter and Full Year 2010 Financial Results on February 28, 2011(2)

February 11, 2011 4:37 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, Feb. 11, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the fourth quarter ended December 31,...

TOPICS:

Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System

February 11, 2011 4:36 am | by Bio-Medicine.Org | Comments

MAHWAH, N.J., Feb. 11, 2011 /- Stryker Corporation's (NYSE: SYK ) Orthopaedics Division today announced U.S. Food and Drug Administration 510(k) clearance for its MDM X3 Modular Dual Mobility Mobile Bearing Hip System.  MDM X3 is an addition to the company's portfolio of...

TOPICS:

Kips Bay Medical, Inc. Announces Pricing of its Initial Public Offering of Common Stock

February 11, 2011 4:36 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS, Feb. 10, 2011 /- Kips Bay Medical, Inc. (Nasdaq: KIPS ) announced today the pricing of the Company's initial public offering of 2,062,500 shares of its common stock at a price of $8.00 per share.  The shares are expected to begin trading on February 11, 2011 on the...

TOPICS:

PerkinElmer's Friel pulls in $3M in restricted stock

February 11, 2011 4:35 am | by Mass High Tech: The Journal of New England Technology | Comments

PerkinElmer Inc. CEO Robert Friel this week received restricted stock worth nearly $3 million and the option to buy about 200,000 shares.

TOPICS:

Lilly Announces Senior Leadership Changes

February 11, 2011 4:35 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, Feb. 11, 2011 /- Eli Lilly and Company (NYSE: LLY ) today announced that Sue Mahony, currently senior vice president of human resources and diversity, has been named senior vice president and president of Lilly Oncology. In this new role she continues to report to John...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading